Same-day assessments · Orange County, CA

Opioid use disorder has the highest overdose mortality of any substance use disorder. Evidence-based treatment — combining medication-assisted treatment (MAT) with therapy and psychiatric support — dramatically improves survival and recovery outcomes.
Free & Confidential
No commitment required. We respond within hours.
HIPAA-compliant · Strictly confidential · No obligation
80K+
US Overdose Deaths / Year
MAT
Gold-Standard Treatment
50%
Relapse Risk Reduction with MAT
1:3
Staff-Client Ratio
Clinical Overview
Opioids include heroin, fentanyl, oxycodone, hydrocodone, morphine, and other prescription and illicit drugs that bind to the mu-opioid receptors in the brain, producing pain relief, euphoria, and sedation. With repeated use, the brain adapts — requiring increasingly higher doses for the same effect and producing intense withdrawal when use stops.
Opioid use disorder (OUD) is the single most lethal substance use disorder — driven in large part by fentanyl contamination of the illicit supply. A single dose can cause fatal respiratory depression. This makes the window for intervention genuinely urgent: OUD is a life-threatening condition that requires immediate, effective treatment.
The neurobiological changes produced by chronic opioid use go beyond physical dependence. The brain's endogenous opioid system — involved in pain regulation, stress response, emotional processing, and social bonding — is profoundly disrupted. Recovery requires time for these systems to normalize.
Medication-assisted treatment (MAT) with buprenorphine-based medications is the gold-standard, evidence-based treatment for OUD — endorsed by SAMHSA, the American Society of Addiction Medicine, and the CDC. MAT dramatically reduces overdose mortality, relapse rates, and criminal justice involvement when delivered alongside appropriate therapy and support.
Next Step
Unsure whether you or a loved one is struggling with addiction? Call our clinical team for a free, confidential assessment at any time.
(949)-461-2620Recognition
Physical dependence — withdrawal symptoms when dose is reduced or missed
Tolerance — needing increasing doses to achieve the same effect
Opioid withdrawal: nausea, vomiting, diarrhea, muscle aches, sweating, insomnia
Track marks, infections, or vein damage with IV use
Constipation, weight loss, and physical neglect
Sedation, slurred speech, and slowed breathing during use
Compulsive use despite knowing it is causing serious harm
Spending disproportionate time and resources obtaining opioids
Doctor shopping, prescription fraud, or using illicit supply
Withdrawal from relationships, work, and responsibilities
Using alone, or using in increasingly risky ways to manage tolerance
Using despite overdoses, hospitalizations, or near-deaths
Recognizing these signs is the first step. Not every symptom needs to be present — if several are familiar, a clinical assessment is warranted.
Why Treatment Matters
Fentanyl contamination of the illicit supply has made opioid overdose an ever-present risk with every single use. Tolerance loss during even brief periods of abstinence (hospitalization, incarceration, prior treatment) makes return to use particularly lethal. Naloxone (Narcan) access is essential — but treatment is the only sustainable solution.
Chronic opioid use disrupts the brain's endogenous opioid system, dysregulating pain processing, stress response, emotional regulation, and social bonding. Protracted withdrawal — persistent dysphoria, anxiety, and sleep disruption lasting weeks to months after acute withdrawal — is a major driver of relapse.
OUD destroys professional functioning, finances, and relationships with a speed and thoroughness matched by few other conditions. The stigma associated with opioid addiction creates additional barriers to care — barriers that our team is committed to dismantling through non-judgmental, evidence-based treatment.
Our Approach
Medically supervised management of opioid withdrawal, followed by induction onto buprenorphine (Suboxone) or buprenorphine/naloxone. MAT dramatically reduces withdrawal discomfort and craving intensity, enabling engagement with the therapeutic dimensions of treatment.
Buprenorphine induction requires careful timing relative to last opioid use to avoid precipitated withdrawal. Our physicians manage this process with precision.
Continued buprenorphine-based MAT throughout PHP, IOP, and outpatient phases. Regular medication reviews, dose optimization, and transition planning as recovery progresses.
Research shows that abrupt discontinuation of MAT significantly increases relapse and overdose risk. Duration of MAT is individualized — there is no clinical mandate to taper before a patient is clinically ready.
Assessment and treatment of co-occurring depression, anxiety, PTSD, or other psychiatric conditions. These are extremely common in OUD and require the same clinical attention as the addiction itself.
Trauma is one of the most prevalent co-occurring conditions in opioid use disorder. EMDR and trauma-informed care are integrated where indicated.
Cognitive Behavioral Therapy addresses relapse triggers, craving management, and the thought patterns underlying opioid use. DBT provides emotional regulation tools. Group therapy builds the peer community that is one of the strongest protective factors in OUD recovery.
Peer support and community connection are particularly important in opioid recovery given the profound social isolation that often accompanies active OUD.
Relapse prevention planning, Narcan access and training, sober housing referrals where appropriate, and ongoing clinical support through the extended recovery process. Alumni program and continuing care are available.
The risk of fatal overdose following a relapse after abstinence is elevated due to tolerance loss. Overdose prevention education is a non-negotiable component of every OUD discharge plan.
Ready to start? Our admissions team conducts a free clinical assessment and recommends the right entry point.
Call NowQuestions
Questions not answered here? Our admissions counselors are available 24 hours a day, 7 days a week.
Technically, 'opiates' refers to naturally derived compounds from the opium poppy (morphine, heroin, codeine), while 'opioids' is the broader term encompassing all drugs that bind to opioid receptors — including semi-synthetic (oxycodone, hydrocodone) and fully synthetic (fentanyl, methadone) compounds. In clinical practice the terms are often used interchangeably, and 'opioid use disorder' (OUD) is the current diagnostic term covering all of these substances.
No. This is one of the most persistent and harmful misconceptions in addiction treatment. Buprenorphine is a partial opioid agonist that, at therapeutic doses, stabilizes opioid receptors without producing the euphoria or dangerous respiratory depression of full agonists. It eliminates withdrawal and dramatically reduces craving — enabling the neurological stability and psychological engagement necessary for recovery. Multiple large-scale clinical trials and decades of real-world evidence demonstrate that MAT with buprenorphine reduces overdose mortality by up to 50%, dramatically outperforming non-medication approaches. Withholding MAT from patients with OUD is not a more rigorous approach to recovery — it is a more dangerous one.
The evidence strongly supports maintaining MAT for at least 1–2 years, and longer for many patients. The risk of relapse and overdose death is significantly elevated in the months following MAT discontinuation — particularly premature discontinuation. The decision to taper off buprenorphine should be made collaboratively between patient and physician when the clinical picture supports it: stable recovery, strong social support, effective coping skills, and genuine intrinsic motivation — not external pressure or arbitrary timelines.
Call 911 immediately and administer naloxone (Narcan) if available. Narcan reverses opioid overdose and is available without a prescription at most pharmacies. If the person is unconscious, perform rescue breathing if trained. Place them in the recovery position to prevent aspiration. Fentanyl overdoses may require multiple Narcan doses. California has a Good Samaritan law protecting individuals who call 911 for an overdose emergency. After the immediate crisis, contact Rize OC for a discussion about treatment options.
Treatment Continuum
Medically supervised opioid withdrawal management and buprenorphine induction.
Learn More
Daily clinical programming with MAT oversight and integrated psychiatric support.
Learn More
Continued MAT management, CBT, and group therapy woven into daily life.
Learn More
Start Recovery at Rize OC
Our admissions team is available around the clock for a free, confidential consultation. Same-day admissions available.